Literature DB >> 22287584

Pressure overload-dependent membrane type 1-matrix metalloproteinase induction: relationship to LV remodeling and fibrosis.

Michael R Zile1, Catalin F Baicu, Robert E Stroud, An Van Laer, Jazmine Arroyo, Rupak Mukherjee, Jeffrey A Jones, Francis G Spinale.   

Abstract

Increased myocardial extracellular matrix collagen represents an important structural milestone during the development of left ventricular (LV) pressure overload (PO); however, the proteolytic pathways that contribute to this process are not fully understood. This study tested the hypothesis that membrane type 1-matrix metalloproteinase (MT1-MMP) is directly induced at the transcriptional level in vivo during PO and is related to changes in LV collagen content. PO was induced in vivo by transverse aortic constriction in transgenic mice containing the full length human MT1-MMP promoter region ligated to luciferase (MT1-MMP Prom mice). MT1-MMP promoter activation (luciferase expression), expression, and activity; collagen volume fraction (CVF); and left atrial dimension were measured at 1 (n = 8), 2 (n = 12), and 4 (n = 17) wk following PO. Non-PO mice (n = 10) served as controls. Luciferase expression increased by fivefold at 1 wk, fell at 2 wk, and increased again by ninefold at 4 wk of PO (P < 0.05). MT1-MMP expression and activity increased at 1 wk, fell at 2 wk, and increased again at 4 wk after PO. CVF increased at 1 wk, remained unchanged at 2 wk, and increased by threefold at 4 wk of PO (P < 0.05). There was a strong positive correlation between CVF and MT1-MMP activity (r = 0.80, P < 0.05). Left atrial dimension remained unchanged at 1 and 2 wk but increased by 25% at 4 wk of PO. When a mechanical load was applied in vitro to LV papillary muscles isolated from MT1-MMP Prom mice, increased load caused MT1-MMP promoter activation to increase by twofold and MT1-MMP expression to increase by fivefold (P < 0.05). These findings challenge the canonical belief that PO suppresses overall matrix proteolytic activity, but rather supports the concept that certain proteases, such as MT1-MMP, play a pivotal role in PO-induced matrix remodeling and fibrosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22287584      PMCID: PMC3330784          DOI: 10.1152/ajpheart.00580.2011

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  43 in total

1.  Membrane-type-1 matrix metalloproteinase transcription and translation in myocardial fibroblasts from patients with normal left ventricular function and from patients with cardiomyopathy.

Authors:  Laura S Spruill; Abigail S Lowry; Robert E Stroud; Christina E Squires; Ira M Mains; English C Flack; Christy Beck; John S Ikonomidis; A Jackson Crumbley; Paul J McDermott; Francis G Spinale
Journal:  Am J Physiol Cell Physiol       Date:  2007-08-01       Impact factor: 4.249

2.  Effects of early and late chronic pressure overload on extracellular matrix remodeling.

Authors:  Jing Lin; Harrison B Davis; Qiuxia Dai; Youn-Min Chou; Teresa Craig; Carmen Hinojosa-Laborde; Merry L Lindsey
Journal:  Hypertens Res       Date:  2008-06       Impact factor: 3.872

3.  A unique substrate binding mode discriminates membrane type-1 matrix metalloproteinase from other matrix metalloproteinases.

Authors:  Steven J Kridel; Hisako Sawai; Boris I Ratnikov; Emily I Chen; Weizhong Li; Adam Godzik; Alex Y Strongin; Jeffrey W Smith
Journal:  J Biol Chem       Date:  2002-04-16       Impact factor: 5.157

4.  A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure.

Authors:  F G Spinale; M L Coker; L J Heung; B R Bond; H R Gunasinghe; T Etoh; A T Goldberg; J L Zellner; A J Crumbley
Journal:  Circulation       Date:  2000-10-17       Impact factor: 29.690

5.  Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic valve disease.

Authors:  Clerio F Azevedo; Marcelo Nigri; Maria L Higuchi; Pablo M Pomerantzeff; Guilherme S Spina; Roney O Sampaio; Flávio Tarasoutchi; Max Grinberg; Carlos Eduardo Rochitte
Journal:  J Am Coll Cardiol       Date:  2010-07-20       Impact factor: 24.094

6.  Differential effects of shear stress and cyclic strain on Sp1 phosphorylation by protein kinase Czeta modulates membrane type 1-matrix metalloproteinase in endothelial cells.

Authors:  Ji Il Kim; Alfredo C Cordova; Yo Hirayama; Joseph A Madri; Bauer E Sumpio
Journal:  Endothelium       Date:  2008 Jan-Feb

Review 7.  Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function.

Authors:  Francis G Spinale
Journal:  Physiol Rev       Date:  2007-10       Impact factor: 37.312

8.  Cyclic strain stimulates early growth response gene product 1-mediated expression of membrane type 1 matrix metalloproteinase in endothelium.

Authors:  Seiichi Yamaguchi; Miho Yamaguchi; Eiji Yatsuyanagi; Sang-Soeb Yun; Nobuyuki Nakajima; Joseph A Madri; Bauer E Sumpio
Journal:  Lab Invest       Date:  2002-07       Impact factor: 5.662

9.  Pressure overload-induced alterations in fibrillar collagen content and myocardial diastolic function: role of secreted protein acidic and rich in cysteine (SPARC) in post-synthetic procollagen processing.

Authors:  Amy D Bradshaw; Catalin F Baicu; Tyler J Rentz; An O Van Laer; Janet Boggs; John M Lacy; Michael R Zile
Journal:  Circulation       Date:  2008-12-31       Impact factor: 29.690

Review 10.  Phagocytosis of collagen by fibroblasts and invasive cancer cells is mediated by MT1-MMP.

Authors:  H Lee; K L Sodek; Q Hwang; T J Brown; M Ringuette; J Sodek
Journal:  Biochem Soc Trans       Date:  2007-08       Impact factor: 5.407

View more
  28 in total

1.  HDACs Regulate miR-133a Expression in Pressure Overload-Induced Cardiac Fibrosis.

Authors:  Ludivine Renaud; Lillianne G Harris; Santhosh K Mani; Harinath Kasiganesan; James C Chou; Catalin F Baicu; An Van Laer; Adam W Akerman; Robert E Stroud; Jeffrey A Jones; Michael R Zile; Donald R Menick
Journal:  Circ Heart Fail       Date:  2015-09-14       Impact factor: 8.790

2.  Lactosylceramide contributes to mitochondrial dysfunction in diabetes.

Authors:  Sergei A Novgorodov; Christopher L Riley; Jin Yu; Jarryd A Keffler; Christopher J Clarke; An O Van Laer; Catalin F Baicu; Michael R Zile; Tatyana I Gudz
Journal:  J Lipid Res       Date:  2016-02-21       Impact factor: 5.922

3.  Myocardial stiffness in patients with heart failure and a preserved ejection fraction: contributions of collagen and titin.

Authors:  Michael R Zile; Catalin F Baicu; John S Ikonomidis; Robert E Stroud; Paul J Nietert; Amy D Bradshaw; Rebecca Slater; Bradley M Palmer; Peter Van Buren; Markus Meyer; Margaret M Redfield; David A Bull; Henk L Granzier; Martin M LeWinter
Journal:  Circulation       Date:  2015-01-30       Impact factor: 29.690

4.  Plasma Biomarkers Reflecting Profibrotic Processes in Heart Failure With a Preserved Ejection Fraction: Data From the Prospective Comparison of ARNI With ARB on Management of Heart Failure With Preserved Ejection Fraction Study.

Authors:  Michael R Zile; Pardeep S Jhund; Catalin F Baicu; Brian L Claggett; Burkert Pieske; Adriaan A Voors; Margaret F Prescott; Victor Shi; Martin Lefkowitz; John J V McMurray; Scott D Solomon
Journal:  Circ Heart Fail       Date:  2016-01       Impact factor: 8.790

5.  Targeted overexpression of tissue inhibitor of matrix metalloproteinase-4 modifies post-myocardial infarction remodeling in mice.

Authors:  Juozas A Zavadzkas; Robert E Stroud; Shenikqua Bouges; Rupak Mukherjee; Jeffrey R Jones; Risha K Patel; Paul J McDermott; Francis G Spinale
Journal:  Circ Res       Date:  2014-03-17       Impact factor: 17.367

6.  Left atrial remodeling, hypertrophy, and fibrosis in mouse models of heart failure.

Authors:  Waqas Hanif; Linda Alex; Ya Su; Arti V Shinde; Ilaria Russo; Na Li; Nikolaos G Frangogiannis
Journal:  Cardiovasc Pathol       Date:  2017-06-21       Impact factor: 2.185

7.  Docosahexaenoic acid reverses angiotensin II-induced RECK suppression and cardiac fibroblast migration.

Authors:  Jalahalli M Siddesha; Anthony J Valente; Tadashi Yoshida; Siva S V P Sakamuri; Patrice Delafontaine; Hideo Iba; Makoto Noda; Bysani Chandrasekar
Journal:  Cell Signal       Date:  2014-01-19       Impact factor: 4.315

8.  Angiotensin II stimulates cardiac fibroblast migration via the differential regulation of matrixins and RECK.

Authors:  Jalahalli M Siddesha; Anthony J Valente; Siva S V P Sakamuri; Tadashi Yoshida; Jason D Gardner; Naveen Somanna; Chiaki Takahashi; Makoto Noda; Bysani Chandrasekar
Journal:  J Mol Cell Cardiol       Date:  2013-10-02       Impact factor: 5.000

Review 9.  Biomarkers of diastolic dysfunction and myocardial fibrosis: application to heart failure with a preserved ejection fraction.

Authors:  Michael R Zile; Catalin F Baicu
Journal:  J Cardiovasc Transl Res       Date:  2013-05-29       Impact factor: 4.132

10.  Cardiac-restricted overexpression or deletion of tissue inhibitor of matrix metalloproteinase-4: differential effects on left ventricular structure and function following pressure overload-induced hypertrophy.

Authors:  William M Yarbrough; Catalin Baicu; Rupak Mukherjee; An Van Laer; William T Rivers; Richard A McKinney; Corey B Prescott; Robert E Stroud; Parker D Freels; Kia N Zellars; Michael R Zile; Francis G Spinale
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-07-03       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.